TUCSON, Ariz.--(BUSINESS WIRE)--High Throughput Genomics, Inc., a provider of novel microplate-based gene expression assay technology and services for the pharmaceutical and life sciences industries, today announced a collaboration agreement with the University of California, San Diego, Department of Medicine, Division of Endocrinology and Metabolism. Under the terms of the agreement, HTG and UCSD will collaborate to generate novel arrays using tissue samples from mice as well as various cell lysates to evaluate genes responsible for inflammation and insulin production using HTG’s qNPA™ quantitative Nuclease Protection Assay technology. Dr. Jerry Olefsky is the lead collaborator on the project for UCSD.
